Go to content

Documents

203 documents

Enter search criteria
Fill in keyword(s) to narrow your search.
Period
You can select a specific type of a document or publication you are looking for, such as press releases or speeches.
Sort by:
Subscribe to the latest documents

  1. Pharmacovigilance of biologicals - Lotte Minnema

    Presentation of Lotte Minnema at the MEB Science Day 2021

    Publication | 18-02-2021

  2. GS-list 18

    The list of active substances in products that may qualify for sale general sale (GS list) was updated by the MEB on 22 October ...

    Policy document | 22-10-2020

  3. Terms and conditions for package fee and reduced fee for copy DCP application - human products

    The term package fee entails that a group of products (each with an individual RVG number) is only billed once at the tariff ...

    Publication | 01-09-2020

  4. Summary - Report on paracetamol and PCA

    Report | 27-08-2020

  5. Report on paracetamol and PCA

    Report | 26-08-2020

  6. MEB 43: Two-round assessment policy for national procedures

    Limiting the number of assessment rounds ensures that the (legally) stipulated time within which the MEB must make a decision ...

    Policy document | 01-08-2020

  7. Strategic Business Plan 2020-2024

    This Strategic Business Plan (SBP) describes the strategic direction of the Medicines Evaluation Board (MEB) in the coming period ...

    Publication | 21-04-2020

  8. MEB 13: Nomenclature of pharmaceutical products

    This document describes the requirements which the marketing authorisation holder has to fulfil when submitting a proposal for a ...

    Policy document | 23-03-2020

  9. MEB Science Day 2020 - Presentation Fiona Sewell

    Publication | 04-03-2020

  10. MEB Science Day 2020 - Presentation Coenraad Hendriksen

    Publication | 04-03-2020

Go to